Algert Global’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Buy
142,900
+33,590
+31% +$224K 0.01% 943
2026
Q1
$596K Sell
109,310
-111,830
-51% -$627K 0.01% 946
2025
Q4
$1.55M Buy
+221,140
New +$1.73M 0.02% 766
2025
Q2
Sell
-47,350
Closed -$377K 1344
2025
Q1
$377K Buy
47,350
+12,920
+38% +$131K 0.01% 965
2024
Q4
$313K Buy
+34,430
New +$332K 0.01% 987
2024
Q3
Sell
-17,069
Closed -$167K 1571
2024
Q2
$167K Sell
17,069
-121,791
-88% -$1.49M 0.01% 1315
2024
Q1
$2.1M Buy
+138,860
New +$2.52M 0.08% 399
2023
Q2
Sell
-141,826
Closed -$3.67M 1261
2023
Q1
$3.67M Buy
+141,826
New +$3.8M 0.17% 169
2022
Q3
Sell
-15,910
Closed -$528K 1337
2022
Q2
$528K Buy
15,910
+10,910
+218% +$463K 0.04% 739
2022
Q1
$361K Buy
+5,000
New +$360K 0.02% 919

Other funds holding TDOC

Algert Global's TDOC Position: Q2 2026 in Review

Algert Global increased its Teladoc Health (TDOC) stake by 31% in Q2 2026, buying an estimated $224K and bringing the position to 142,900 shares worth $1.21M. The position accounts for 0.01% of the portfolio, ranked #943.

Algert Global first reported a position in TDOC in Q1 2022 and has held it in 10 quarters since. The position peaked at $3.67M in Q1 2023. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Algert Global held 142,900 shares of Teladoc Health worth $1.21M as of Q2 2026.
  • Algert Global bought 33,590 Teladoc Health shares in Q2 2026, an estimated $224K.
  • Teladoc Health made up 0.01% of Algert Global's portfolio in Q2 2026, its #943 holding.
  • Algert Global first reported a position in Teladoc Health in Q1 2022 and has held it in 10 quarters since.
  • Algert Global's Teladoc Health position peaked at $3.67M in Q1 2023.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.